3Sasaki, Maeda Y, kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence [ J ] . Gan To Kagaku Ryoho, 2000,27(2): 166-176.
4Bang Y J, knag WK, knag YK, et al. Docetaxel 75 mg / m2 is active and well tolerate in patients with metastatic or recurrent gastric cancer: a phase Ⅱ trial [ J ] . Jpn J Clin Oncol,2002,32:248-254.
5Ajani JA. Docetaxel in combination for advanced gastric cancer [ J ] .Gastric Cancer, 2002, 5(Suppl 1):31-34.
6Hailer DG, Misset JL. Docetaxel in advanced gastric cancer [ J ] .Anticancer Drugs, 2002, 13(5):451-460.
7De Vita F,Orditura M, Matano E, et al, A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients [J].Br J Cancer, 2005, 92(9):1644- 1649.
8De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
9Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
10Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
